Ensuring tight control in patients with rheumatoid arthritis treated with targeted therapies during the COVID-19 pandemic using a telehealth strategy
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-220142
Abstract: COVID-19 pandemic in its early months has deeply influenced rheumatic patients’ followup in terms of treatment adherence, disease control achieved with treattotarget and tightcontrol strategies. Nationwide mitigation strategies such as confinement, travel restrictions and inadequate… read more here.
Keywords: control; remission; online supplemental; covid pandemic ... See more keywords
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2022-222264
Abstract: Prompt identification of patients with rheumatoid arthritis (RA), ideally within a window of opportunity of approximately 12 weeks, increases potential for antirheumatic treatments to dampen the inflammatory process in a milder and more reversible stage… read more here.
Keywords: rheumatology; time; presentation; online supplemental ... See more keywords
Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials
Sign Up to like & getrecommendations! Published in 2023 at "Gut"
DOI: 10.1136/gutjnl-2023-329826
Abstract: We read the Maastricht VI/Florence consensus report published in GUT with great interest. The report suggested that vonoprazanbased therapy is superior, or not inferior, to conventional proton pump inhibitor (PPI)based triple therapies for Helicobacter pylori… read more here.
Keywords: triple therapy; online supplemental; pylori eradication; therapy ... See more keywords
A polymorphic AT-repeat causes frequent allele dropout for an MME mutational hotspot exon
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Genetics"
DOI: 10.1136/jmedgenet-2021-108281
Abstract: Pathogenic variants in the MME gene cause dominant and recessive lateonset axonal hereditary neuropathy, that is, axonal CharcotMarieTooth syndrome (LOCMT2). Here, we report nextgeneration sequencing (NGS) and Sanger sequencing (SS) results of 28 LOCMT2 patients… read more here.
Keywords: online supplemental; mme variants; allele dropout; 467del pro156leufs ... See more keywords